| Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127) |
|---|
| 08/25/2005 | US20050187393 Isolated, purified phytyltrimethylhydroquinone is cyclized to alpha-tocopherol with use of acid catalyst such as sulfuric acid, phosphoric acid, a polyperfluoroalkylenesulphonic acid, a heteropoly acid, zinc chloride, boron trifluoride, aluminium trichloride, or a mixture |
| 08/25/2005 | US20050187272 Enzyme inhibitor on NO-synthase enzymes; treating STROKE, NEURODEGENERATIVE DISEASES, preventing ISCHEMIC OR HEMORRAGIC CARDIAC OR CEREBRAL INFARCTIONS; inhibiting lipidic peroxidation |
| 08/25/2005 | US20050187263 Oxydecahydronaphthalene modulators of HM74 |
| 08/25/2005 | US20050187110 Novel herbicides |
| 08/25/2005 | US20050186176 Compounds and compositions for delivering active agents |
| 08/25/2005 | CA2555884A1 Amino-substituted tricyclic derivatives and methods of use |
| 08/24/2005 | EP1565443A2 Acetyl 2-hydroxy-1,3 diaminoalkanes |
| 08/24/2005 | EP1565428A1 Substituted ureas and carbamates |
| 08/24/2005 | CN1659640A Optical data carrier comprising a cationic aminoheterocyclic dye as light-absorbent compound in the information layer |
| 08/24/2005 | CN1659159A Benzopyranone compounds, compositions thereof, and methods of treatment therewith |
| 08/24/2005 | CN1659130A Induction of apoptosis in cancer cells |
| 08/24/2005 | CN1658828A Gallocatechin gallate-containing composition |
| 08/24/2005 | CN1658724A Luminescent element material and luminescent element comprising the same |
| 08/24/2005 | CN1216151C Method for extracting isoflavone from soybean |
| 08/24/2005 | CN1215835C Ketone derivatives and medical use thereof |
| 08/23/2005 | US6933396 Process to prepare psorospermin |
| 08/23/2005 | US6932990 Comprises solvent extract of compressed cake derived from defatted evening primrose seed wherein effective component contains polyphenol-essential elements such as ellagic acid, gallic acid, pentagalloylglucose and catechin |
| 08/23/2005 | CA2153235C Compounds having selectivity for retinoid x receptors |
| 08/18/2005 | WO2005075463A1 Benzopyran derivatives, method of production and use thereof |
| 08/18/2005 | WO2005075449A1 Compounds and methods to increase anti-p-glycoprotein activity of baicalein by alkylation on the a ring |
| 08/18/2005 | WO2005075448A2 A method for manufacturing optically pure coumaryl amino acids salts and the coumaryl amino acid salts thus obtained |
| 08/18/2005 | WO2005074906A1 Remedy |
| 08/18/2005 | WO2005062852A3 COMPOSITIONS CONTAINING d-TOCOPHEROL COMPOUND POLYBASIC ACID PARTIAL ESTERS |
| 08/18/2005 | WO2005047242A3 Compounds containing thiosulfate moieties |
| 08/18/2005 | US20050182269 Process for the preparation of 3-cyano-1-naphthoic acid and some analogues thereof |
| 08/18/2005 | US20050182068 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
| 08/18/2005 | US20050182050 Therapeutic heterocyclic compounds |
| 08/18/2005 | US20050182035 cyclohexane ring is 3,5-dihydroxy-substituted and 2,4-alkylene-bridged; treating metabolic bone disease, cancer, skin disorders, immune system disorders, asthma, hypertension, hypothyroidism, hypocalcemia, female infertility and alopecia |
| 08/18/2005 | US20050182034 Method of locking 1alpha-OH of vitamin D compounds in axial orientation |
| 08/18/2005 | US20050178289 Novel colorant compound, ink, ink tank, recording unit, recording apparatus and recording process |
| 08/18/2005 | CA2554140A1 Methods and compositions for treating cancer |
| 08/17/2005 | EP1564258A1 Colourant compound, ink, ink tank, recording unit, recording apparatus and recording process |
| 08/17/2005 | EP1563841A1 Remedies |
| 08/17/2005 | EP1562929A1 Manufacture of tocopheryl acetate |
| 08/17/2005 | EP1562895A1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 08/17/2005 | EP1360183B1 Novel photochromic indenonaphthopyran compounds |
| 08/17/2005 | EP1280757B1 New gamma selective retinoids |
| 08/17/2005 | EP1236724B1 Neutralizing agent for toxin of microorganism belonging to the genus clostridium |
| 08/17/2005 | CN1656088A Substituted chroman derivatives having cytochrome P450RAI inhibitory activity |
| 08/17/2005 | CN1655806A Treatment of diseases involving defective gap junctional communication |
| 08/17/2005 | CN1655776A Anti-constipation composition |
| 08/17/2005 | CN1654547A Novel pigment compound, ink, ink cartridge, recording element, recording device and recording method |
| 08/17/2005 | CN1654464A N, N'-disubstituted dihydrazides compound and its preparing process and application thereof |
| 08/17/2005 | CN1654463A Procyanidins oligomer and its preparing method and use |
| 08/17/2005 | CN1654462A Antineoplastic cocoa extracts and methods for making and using the same |
| 08/17/2005 | CN1215032C Process for preparing extract containing hypericin and flavon compounds |
| 08/16/2005 | US6930191 Reaction of calcium compound with tocopherol acid compound in CO2 to form salt |
| 08/16/2005 | CA2238521C Diaminopyrimidines, pharmaceutical compositions containing them and their use as antibacterial |
| 08/11/2005 | WO2005073212A1 Process for producing chroman compound |
| 08/11/2005 | WO2005073205A1 Selective estrogen receptor modulators |
| 08/11/2005 | WO2005073204A1 Selective estrogen receptor modulators for the treatment of vasomotor symptoms |
| 08/11/2005 | WO2005073190A1 Selective estrogen receptor modulators |
| 08/11/2005 | WO2005072762A1 Compositions enriched in phenolic compounds and methods for producing the same |
| 08/11/2005 | WO2005056510A3 Novel ligands that are activators of the rar receptors, use in human medicine and in cosmetics |
| 08/11/2005 | WO2005054222A3 Flavonoid derivative |
| 08/11/2005 | WO2005000233A3 Novel therapeautic agents for the treatment of cancer, metabolic diseases and skin disorders |
| 08/11/2005 | US20050176939 Using temperature variation to isolate epigallocatechin (EGC) and epigallocatechin gallate (EGCG) from green and/or white tea |
| 08/11/2005 | US20050176808 Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof |
| 08/11/2005 | US20050176758 2-(hydroxy or methoxymethoxy)-4-(carboxy or alkoxycarbonyl)-5-(fluoro or hydrogen)-7-oxabicyclo(4.1.0)hept-3-ene chemical intermediates to neuraminidase inhibitors |
| 08/11/2005 | US20050176750 Treating proliferative disorders such as cancer, autoimmune or inflammatory diseases such as psoriasis; e.g. 4-(3-Bromo-4,5-dimethoxyphenyl)-3-cyano-7-dimethylamino-4H-chromene; use with known anticancer drugs or radiotherapy |
| 08/11/2005 | US20050176712 Integrin expression inhibitor |
| 08/11/2005 | US20050176689 For therapy, useful as regulators of cell proliferation and differentiation, and particularly as agents for treating skin-related diseases |
| 08/11/2005 | US20050175751 Comprising pulverization, fermention, first and second filtrations, extraction, and drying; by fermenting the soybeans, cell walls on seed coats of the soybeans are destroyed to release a high level of isoflavon and high level of soybean enzyme by-product that is suitable as high added-value feed |
| 08/11/2005 | CA2554182A1 Compositions enriched in phenolic compounds and methods for producing the same |
| 08/10/2005 | EP1560893A1 Photochromic compositions and light transmissible articles |
| 08/10/2005 | EP1560819A1 Cannabinoid crystalline derivatives and process of cannabinoid purification |
| 08/10/2005 | EP1560576A2 Synthesis of oligomeric epicatechin and catechin-derived procyanidins |
| 08/10/2005 | EP1399406B1 Novel estrogen receptor ligands and methods i |
| 08/10/2005 | EP0833622B1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor |
| 08/10/2005 | CN1653058A Process for the preparation of 3-isochromanone |
| 08/10/2005 | CN1651424A Production method of high purity tea polyphenol and caffeine |
| 08/10/2005 | CN1651423A Felt wort extract, its preparation method and use |
| 08/10/2005 | CN1651392A 2-and 2, 5-substituted phenylketoenols |
| 08/10/2005 | CN1214021C Process for producing isocoumarins and intermediates for same |
| 08/10/2005 | CN1214020C Preparation of isoflavones from legumes |
| 08/09/2005 | US6927224 Anticancer agents; osteoporosis |
| 08/09/2005 | US6927057 Macrolide analogs |
| 08/09/2005 | US6926914 Proanthocyanidin-containing composition |
| 08/09/2005 | CA2327029C Method for making 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline |
| 08/09/2005 | CA2310627C Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists |
| 08/09/2005 | CA2105518C Condensed heterocyclic compounds, their production and use |
| 08/04/2005 | WO2005070936A1 20-esterized camptothecin derivatives, their preparation and the pharmaceutical compositions and the use |
| 08/04/2005 | WO2005070910A2 Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme |
| 08/04/2005 | WO2005070871A2 Amino alcohol derivatives and their activity as renin inhibitors |
| 08/04/2005 | WO2005070405A1 Alpha-aminoamide derivatives useful in the treatment of lower urinary tract disorders |
| 08/04/2005 | US20050171362 alkenylated aromatic compounds featuring at least one hydroxy group, their ring-closure reactions to chroman derivatives; manufacture of tocols, tocopherols and their alkanoates such as alpha -tocopherol (TCP) and alkanoates; indium salt as the catalyst |
| 08/04/2005 | US20050171361 Production of delta 9 tetrahydrocannabinol |
| 08/04/2005 | US20050171356 Pesticidal (dihalopropenyl) phenylalkyl substituted benzoxazole and benzothiazole derivatives |
| 08/04/2005 | US20050171354 Heterocyclic amines such as (2S,3S)-3-((1R)-6-methoxy-1-methyl -1-trifluoromethylisochroman-7-yl)methylamino-2-phenyl piperidine, used as analgesics, antiinflammatory agents, or for prophylaxis of cardiovascular disorders |
| 08/04/2005 | US20050171190 Substituted 5-chroman-5-YL-ethylamine compounds and their use for the treatment of glaucoma |
| 08/04/2005 | US20050171151 Administering retinoic acid receptors (RAR) antagonist or an RAR inverse agonist for therapy of hyperlipidemia in mammal |
| 08/04/2005 | US20050171149 antioxidant properties and peroxisome proliferator activated receptors (PPAR) alpha and PPAR gamma activator properties; cardiovascular diseases, syndrome X, restenosis, diabetes, obesity, hypertension, inflammatory diseases, cancers or neoplasms, neurodegenerative, and skin disorders |
| 08/04/2005 | US20050171079 2,7-bis-[(3R)-1-azabicyclo[2.2.2]octan-3-yloxy]-fluoren-9-one; 2,7-bis[(2R)-azetidin-2-ylmethoxy]-fluoren-9-one; alpha 7 Nicotinic acetylcholine receptors ligands; cognitive disorder, neurodegeneration, and neurodevelopmental disorders |
| 08/04/2005 | US20050171031 Method and composition for the treatment of cancer |
| 08/04/2005 | US20050170363 For conjugation with biomolecules, drugs, and toxins |
| 08/04/2005 | DE102004002607A1 Visualisierung von Sonnenschutzmitteln auf der Haut Visualization of sunscreen on the skin |
| 08/04/2005 | DE10012962B4 Verfahren zur Parallelsynthese von mindestens zwei Cumarinderivaten sowie substituierte Cumarinderivate und Arylboronsäurepropandiolester A method for parallel synthesis of at least two coumarin derivatives and substituted coumarin derivatives and Arylboronsäurepropandiolester |
| 08/04/2005 | CA2554047A1 Alpha-aminoamide derivatives useful in the treatment of lower urinary tract disorders |
| 08/04/2005 | CA2553840A1 Amino alcohol derivatives and their activity as renin inhibitors |
| 08/03/2005 | EP1559713A1 Chromene compound |